1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News NOVEMBER 2014

Respiratory Therapy News NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - AstraZeneca Fast-Tracks Into Up-And-Coming LABA/LAMA Market
Industry Trend Analysis - Overwhelming COPD Market Will Dent Sunovion's Ambitions
Industry Trend Analysis - GSK Collaboration Boosts Clovis In Race For Third-Generation NSCLC Drug
Industry Brief - Merck's Keytruda Gains FDA Breakthrough Therapy Designation For Advanced NSCLC
Industry Brief - GSK Files Regulatory Submissions For Mepolizumab In Severe Eosinophilic Asthma
Industry Brief - AirFluSal Forspiro Approved In Ireland/Czech Republic
Industry Trend Analysis - Merck KGaA/Pfizer Alliance Is Strategic Move For Both In Immuno-Oncology
Industry Brief - BI Reports Positive Phase III Results For Afatinib In Asian NSCLC Patients With del19 Mutation
Industry Brief - Spiriva HandiHaler/Striverdi Respimat Co-Administration Improves Lung Function In COPD Patients
Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market
Industry Brief - FDA Accepts Boehringer's NDA For Additional Spiriva Respimat Indication
Industry Brief - Five Prime/GSK Expand Research Collaboration For Respiratory Diseases
Industry Brief - Enrolment Begins In Bronchitol Phase III CF Trial
Industry Brief - Vertex Submits Lumacaftor+Ivacaftor Applications In US/Europe
Industry Brief - Phase II Trial Of Cabozantinib/Erlotinib Shows Positive Top-Line Results
Industry Brief - Positive Results Reported From Dupilumab Phase IIb Study In Moderate-To-Severe Asthma

Table Of Contents

Respiratory Therapy News NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.